1. Home
  2. ACCS vs OKYO Comparison

ACCS vs OKYO Comparison

Compare ACCS & OKYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACCS
  • OKYO
  • Stock Information
  • Founded
  • ACCS 1988
  • OKYO 2007
  • Country
  • ACCS United States
  • OKYO United Kingdom
  • Employees
  • ACCS N/A
  • OKYO N/A
  • Industry
  • ACCS Publishing
  • OKYO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ACCS Consumer Discretionary
  • OKYO Health Care
  • Exchange
  • ACCS Nasdaq
  • OKYO Nasdaq
  • Market Cap
  • ACCS 44.2M
  • OKYO 37.0M
  • IPO Year
  • ACCS N/A
  • OKYO 2022
  • Fundamental
  • Price
  • ACCS $11.75
  • OKYO $2.79
  • Analyst Decision
  • ACCS Strong Buy
  • OKYO Strong Buy
  • Analyst Count
  • ACCS 1
  • OKYO 1
  • Target Price
  • ACCS $15.00
  • OKYO $7.00
  • AVG Volume (30 Days)
  • ACCS 10.0K
  • OKYO 161.4K
  • Earning Date
  • ACCS 08-07-2025
  • OKYO 08-12-2025
  • Dividend Yield
  • ACCS N/A
  • OKYO N/A
  • EPS Growth
  • ACCS N/A
  • OKYO N/A
  • EPS
  • ACCS N/A
  • OKYO N/A
  • Revenue
  • ACCS $22,961,000.00
  • OKYO N/A
  • Revenue This Year
  • ACCS $7.67
  • OKYO N/A
  • Revenue Next Year
  • ACCS N/A
  • OKYO N/A
  • P/E Ratio
  • ACCS N/A
  • OKYO N/A
  • Revenue Growth
  • ACCS 6.92
  • OKYO N/A
  • 52 Week Low
  • ACCS $7.79
  • OKYO $0.81
  • 52 Week High
  • ACCS $13.35
  • OKYO $3.11
  • Technical
  • Relative Strength Index (RSI)
  • ACCS N/A
  • OKYO 60.69
  • Support Level
  • ACCS N/A
  • OKYO $2.05
  • Resistance Level
  • ACCS N/A
  • OKYO $3.10
  • Average True Range (ATR)
  • ACCS 0.00
  • OKYO 0.18
  • MACD
  • ACCS 0.00
  • OKYO 0.00
  • Stochastic Oscillator
  • ACCS 0.00
  • OKYO 69.24

About ACCS ACCESS Newswire Inc. Common Stock

ACCESS Newswire Inc is a Public Relations (PR) and Investor Relations (IR) solutions provider. The group focuses on innovation, customer service, and value-driven offerings, ACCESS Newswire empowers brands.

About OKYO OKYO Pharma Limited

OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.

Share on Social Networks: